All In MedTech

Device Trial Radar · NCT07286513

Persona SoluTion PPS Femur PMCF

A Prospective, Multi-Center Post-Market Clinical Study Evaluating the Safety, Performance, and Clinical Benefits of the Persona® SoluTion® PPS Femur

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

200

Planned (sponsor's estimate)

Start

Feb 26, 2026

Primary completion

Dec 2029

Study completion Dec 2037

Sponsor

Lead sponsor
Zimmer BiometPublic (ZBH)
Sponsor type
Industry
First posted
Dec 16, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to generate clinical evidence and evaluate the safety and performance of the Persona® SoluTion® PPS Femurs in the US market, with data supporting global regulatory submissions, including CE marking under EU MDR. The target population consists of adults undergoing knee arthroplasty with the Persona SoluTion femoral component paired with a Medial Congruent (MC) or Posterior Stabilized (PS) articulating surface in line with its current cleared Instructions for Use (IFU). The primary endpoint is the assessment of clinical performance and benefits by evaluating the average change in the KOOS JR score between pre-operative and 2-year post-operative follow-up.

Conditions

  • Rhematoid Arthritis
  • Osteo Arthritis of the Knee
  • Traumatic Arthritis of Knee (Diagnosis)
  • Polyarthritis
  • Collagen Disorders
  • Avascular Necrosis of Femoral Condyle
  • Valgus Deformity
  • Varus Deformity
  • Flexion Deformity of Knee

Interventions

  • Total knee arthroplastyDevice

    The screening population will consist of patients for whom clinical decision has been made to use the Persona® SoluTion® PPS femoral implant in total knee arthroplasty prior to enrollment in the research.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in KOOS JR Score between pre-op and 2 years post-opTime frame: 2 years

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Denver Hip and Knee, Inc.

    Denver, Colorado

  • AdventHealth Porter

    Denver, Colorado

  • Norton Orthopedic Institute

    Louisville, Kentucky

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.